DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / American depositary shares, each representing one equity share
Symbol
RDY on NYSE
Shares outstanding
834,731,296
Price per share
$14.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
106,984,426
Total reported value
$1,495,634,075
% of total 13F portfolios
0%
Share change
-1,238,360
Value change
-$18,856,355
Number of holders
226
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Prasad G V 14% $1,607,395,312 113,356,510 K. Satish Reddy 17 Sep 2025

As of 30 Sep 2025, 226 institutional investors reported holding 106,984,426 shares of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY). This represents 13% of the company’s total 834,731,296 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Robeco Institutional Asset Management B.V. 1.6% 13,084,506 +7.6% 0.26% $182,921,393
BlackRock, Inc. 1.3% 11,160,398 +6.9% 0% $156,022,358
ROYAL BANK OF CANADA 1.2% 10,162,215 +2% 0.03% $142,067,000
RENAISSANCE TECHNOLOGIES LLC 1.1% 8,782,628 -2.6% 0.16% $122,781,139
Aikya Investment Management Ltd 0.8% 6,715,007 +5.7% 26% $93,875,798
MORGAN STANLEY 0.76% 6,322,154 +30% 0.01% $88,383,738
JPMORGAN CHASE & CO 0.72% 6,027,710 +2% 0.01% $84,267,386
DIMENSIONAL FUND ADVISORS LP 0.64% 5,352,887 -0.88% 0.02% $74,829,729
VANGUARD GROUP INC 0.61% 5,123,709 +3% 0% $71,629,453
STATE STREET CORP 0.5% 4,158,331 -0.81% 0% $58,133,467
BNP PARIBAS FINANCIAL MARKETS 0.48% 4,003,182 0% 0.04% $55,964,484
ACADIAN ASSET MANAGEMENT LLC 0.24% 2,004,747 -5.3% 0.05% $28,019,000
Fisher Asset Management, LLC 0.2% 1,681,411 -17% 0.01% $23,506,125
BESSEMER GROUP INC 0.16% 1,350,988 +31% 0.03% $18,887,000
Creative Planning 0.15% 1,262,891 +15% 0.01% $17,655,211
UBS Group AG 0.15% 1,232,280 +2.1% 0% $17,227,275
AMERICAN CENTURY COMPANIES INC 0.14% 1,192,048 +14% 0.01% $16,664,831
JANE STREET GROUP, LLC 0.14% 1,180,455 +18% 0.02% $16,502,761
NORTHERN TRUST CORP 0.13% 1,119,421 -0.03% 0% $15,649,506
LAZARD ASSET MANAGEMENT LLC 0.09% 770,025 +11% 0.01% $10,764,950
GOLDMAN SACHS GROUP INC 0.08% 695,475 +7.4% 0% $9,722,736
Caisse de depot et placement du Quebec 0.07% 566,200 +168% 0.01% $7,915,476
MILLENNIUM MANAGEMENT LLC 0.07% 555,859 -64% 0.01% $7,770,909
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.05% 430,938 0% 0% $6,024,513
Grantham, Mayo, Van Otterloo & Co. LLC 0.05% 416,233 +82% 0.02% $5,818,937

Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 753,722 $10,571,209 -$209,779 $14.04 22
2025 Q3 106,984,426 $1,495,634,075 -$18,856,355 $13.98 226
2025 Q2 107,490,178 $1,615,554,376 -$2,437,810 $15.03 239
2025 Q1 109,524,880 $1,444,575,514 -$147,672,656 $13.19 238
2024 Q4 118,404,230 $1,868,450,580 +$1,377,376,441 $15.79 244
2024 Q3 22,288,494 $1,770,704,586 -$33,393,363 $79.45 218
2024 Q2 24,100,699 $1,836,647,538 +$26,277,340 $76.19 219
2024 Q1 23,590,141 $1,729,884,201 +$4,044,030 $73.35 228
2023 Q4 99,585 $6,929,124 +$184,370 $69.58 2
2023 Q3 19,651,005 $1,313,987,063 +$168,493,172 $66.87 205
2023 Q2 17,828,054 $1,125,045,600 +$125,327,132 $63.11 186
2023 Q1 15,857,429 $902,616,808 +$137,000,446 $56.93 184
2022 Q4 13,395,970 $693,189,601 +$9,913,252 $51.75 157
2022 Q3 13,282,850 $696,185,025 +$47,160,678 $52.34 145
2022 Q2 12,415,462 $684,574,836 -$25,432,656 $55.39 146
2022 Q1 16,608,544 $923,504,856 +$5,953,697 $55.73 144
2021 Q4 16,495,219 $1,072,923,887 -$46,326,592 $65.41 140
2021 Q3 16,962,451 $1,105,428,925 -$95,431,992 $65.14 144
2021 Q2 15,044,761 $1,105,756,524 +$18,366,853 $73.51 156
2021 Q1 18,276,696 $1,128,125,282 -$12,076,669 $61.39 159
2020 Q4 15,571,208 $1,110,887,218 -$141,046,839 $71.29 168
2020 Q3 17,188,472 $1,193,465,793 -$19,473,778 $69.56 179
2020 Q2 17,961,051 $951,743,854 +$24,432,982 $53.01 166
2020 Q1 21,304,625 $860,309,678 -$4,454,568 $40.33 141
2019 Q4 21,368,912 $867,262,792 +$19,341,875 $40.58 140
2019 Q3 20,981,662 $795,267,395 -$26,245,340 $37.89 146
2019 Q2 21,633,367 $810,687,463 +$17,859,931 $37.47 144
2019 Q1 21,121,802 $855,481,692 +$29,781,341 $40.50 139
2018 Q4 20,404,284 $769,200,246 +$59,308,340 $37.70 139
2018 Q3 18,898,660 $650,159,052 -$42,388,730 $34.60 120
2018 Q2 20,321,274 $654,370,435 -$56,117,130 $32.20 129
2018 Q1 21,776,394 $711,487,019 +$199,061 $32.69 118
2017 Q4 21,751,455 $816,946,752 -$23,656,355 $37.56 115
2017 Q3 22,729,401 $811,012,307 -$47,707,928 $35.68 116
2017 Q2 25,171,379 $1,060,474,046 +$7,823,915 $42.14 124
2017 Q1 24,921,678 $1,000,777,481 -$47,387,993 $40.15 129
2016 Q4 27,216,853 $1,233,105,684 +$10,921,064 $45.28 157
2016 Q3 26,577,845 $1,234,453,911 -$10,447,741 $46.42 151
2016 Q2 26,821,658 $1,391,181,368 -$11,487,888 $51.23 152
2016 Q1 26,597,618 $1,207,259,901 -$77,651,887 $45.19 153
2015 Q4 28,123,106 $1,305,218,971 -$1,109,238 $46.29 165
2015 Q3 27,913,643 $1,783,489,511 +$178,377,572 $63.91 198
2015 Q2 24,774,646 $1,370,319,095 +$39,764,343 $55.32 182
2015 Q1 24,461,037 $1,394,287,270 -$54,808,254 $57.10 168
2014 Q4 25,467,719 $1,284,473,102 +$45,925,036 $50.45 163
2014 Q3 24,228,400 $1,273,181,851 -$18,263,249 $52.55 156
2014 Q2 25,545,596 $1,102,757,269 +$39,844,000 $43.15 167
2014 Q1 24,292,000 $1,065,614,568 +$90,302,343 $43.90 165